Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

This Week in AI (Mar 22-28): Anthropic/Moonshot Eyeing IPOs; TurboQuant Rattles Memory Stocks

This Week in AI (Mar 29 – Apr 4): OpenAI Pre-IPO $122bn Fundraising; Zhipu Results; Google Gemma 4

This Week in AI (Apr 5-11): Anthropic's Mythos Is Too Dangerous; Zhipu Tops Bench on Huawei Chips

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Bottom-Up

<ul>
<li>We tracked AI models, infrastructure, and M&amp;A this week: Jensen Huang endorsed OpenClaw at GTC 2026.</li>
<li>MiniMax launched self-evolving M2.7. Zhipu released GLM-5-Turbo optimized for OpenClaw. Alibaba and Tencent restructured AI operations.</li>
<li>Google closed $32bn Wiz deal. Anthropic and OpenAI shipped new products. Cursor's Composer 2 built on Kimi K2.5.</li>
</ul>


We tracked AI models, infrastructure, and M&amp;A this week: Jensen Huang endorsed OpenClaw at GTC 2026.
MiniMax launched self-evolving M2.7. Zhipu released GLM-5-Turbo optimized for OpenClaw. Alibaba and Tencent restructured AI operations.
Google closed $32bn Wiz deal. Anthropic and OpenAI shipped new products. Cursor's Composer 2 built on Kimi K2.5.


This Week in AI (Mar 15-21): Jensen Huang Endorses OpenClaw; MiniMax/Zhipu New Model